by The pharmaceutical water market involves purification systems used to produce high purity water for the pharmaceutical and biotechnology industries. Key products in this space include municipal water treatment systems, deionized water systems, reverse osmosis systems and ultraviolet light disinfection systems. The need for pure and microbiologically safe water has become crucial given the contamination risks it poses when used during manufacturing of active pharmaceutical ingredients or in their formulations.
The global pharmaceutical water market is estimated to be valued at US$ 7.22 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the pharmaceutical water market are Heidelberg Printing Machinery AG, Komori Corporation, Koenig & Bauer AG, Manroland Goss web systems, HP Inc., Xerox Corporation, Canon Inc., Ricoh Company, Ltd., Epson, Konica Minolta, Inc. Key players focus on developing innovative water purification systems targeted towards pharmaceutical and biotech applications.
The growing Pharmaceutical Water Market Demand for safe and high quality medicines is propelling the need for purified water across manufacturing units. Stringent regulations ensure utilization of water meeting prescribed quality standards at all stages of drug production. The biologics manufacturing market in particular is driving significant uptake of advanced water treatment technologies.
Global expansion of top players through collaborations and acquisitions have augmented accessibility of technology and expertise in emerging pharma hubs of Asia Pacific and Latin America. Regional healthcare authorities are also strengthening water quality monitoring to boost compliance.
Market key trends
The rising emphasis on continuous manufacturing presents favorable prospects. Advanced connected systems for real-time water quality monitoring and validation are gaining popularity. Manufacturers focus on the seamless integration of purification equipment with process automation infrastructure to achieve enhanced production efficiency and flexibility.
Porter’s Analysis
Threat of new entrants: The Pharmaceutical Water Market requires high capital investment and strict regulatory norms which makes the entry difficult for new players.
Bargaining power of buyers: Pharmaceutical companies have significant bargaining power over water purification equipment providers due to consolidation in the pharmaceutical industry.
Bargaining power of suppliers: Suppliers of raw materials have moderate bargaining power as raw material suppliers are fragmented.
Threat of new substitutes: There exists few substitutes for water purification equipment and technologies in pharmaceutical applications.
Competitive rivalry: The global pharmaceutical water market is highly competitive and fragmented with the presence of both international and domestic players.
Geographical Regions
North America currently holds the largest share of the global pharmaceutical water market, primarily due to stringent regulatory guidelines regarding water purification in pharmaceutical applications. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period owing to increasing generic drug manufacturing, rising health awareness, and growing medical tourism in countries such as India and China.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
